Evidence map›Paper›PMID 35268590›Full record

ArticleMolecules (Basel, Switzerland)2022

Brain Iron Deficiency Changes the Stoichiometry of Adenosine Receptor Subtypes in Cortico-Striatal Terminals: Implications for Restless Legs Syndrome.

Matilde S Rodrigues, Samira G Ferreira, César Quiroz, Christopher J Earley, Diego García-Borreguero, Rodrigo A Cunha, Francisco Ciruela, Attila Köfalvi, Sergi Ferré

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Dopaminergic hypersensitivity of the opioid-responsive striatal-entopeduncular pathway in a rodent model of restless legs syndrome.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Lateral septum adenosine ANature communications · 2023
    Article
  8. Article
  9. Circadian rhythm in restless legs syndrome.Frontiers in neurology · 2023
    Review
  10. The ADORA1 mutation linked to early-onset Parkinson's disease alters adenosine ABiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
    Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Matilde S RodriguesCNC-Center for Neuroscience and Cell Biology of Coimbra, University of Coimbra, 3004-504 Coimbra, Portugal.ORCID 0000-0002-9616-8400
Samira G FerreiraCNC-Center for Neuroscience and Cell Biology of Coimbra, University of Coimbra, 3004-504 Coimbra, Portugal.
César QuirozIntegrative Neurobiology Section, National Institute on Drug Abuse, Baltimore, MD 21224, USA.
Christopher J EarleyDepartment of Neurology, Johns Hopkins University, Baltimore, MD 21224, USA.
Diego García-BorregueroSleep Research Institute, 28036 Madrid, Spain.
Rodrigo A CunhaCNC-Center for Neuroscience and Cell Biology of Coimbra, University of Coimbra, 3004-504 Coimbra, Portugal.ORCID 0000-0003-2550-6422
Francisco CiruelaPharmacology Unit, Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Institute of Neurosciences, University of Barcelona, 08907 L'Hospitalet de Llobregat, Spain.ORCID 0000-0003-0832-3739
Attila KöfalviCNC-Center for Neuroscience and Cell Biology of Coimbra, University of Coimbra, 3004-504 Coimbra, Portugal.ORCID 0000-0001-6910-9707
Sergi FerréIntegrative Neurobiology Section, National Institute on Drug Abuse, Baltimore, MD 21224, USA.ORCID 0000-0002-1747-1779
University of Coimbra · PTNational Institute on Drug Abuse · USInstitut d'Investigació Biomédica de Bellvitge · ESJohns Hopkins University · US

Funding

Neurotransmitter Receptor Heteromers in the Striatal Spine ModuleZIADA000493 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI FERRE, SERGI · 2009 to 2025
$35.6M
European Regional Development Fund (ERDF), through the Centro 2020 Regional Operational Program, and through the COMPETE 2020 - Operational Program for Competitiveness and Internationalization and Portuguese national funds UIDB/04539/2020 and UIDP/04539/2020 of FCTLa Caixa Foundation LCF/PR/HP17/52190001NIDA NIH HHS Intramural Funds
6 · The paper itself

Abstract

Brain iron deficiency (BID) constitutes a primary pathophysiological mechanism in restless legs syndrome (RLS). BID in rodents has been widely used as an animal model of RLS, since it recapitulates key neurochemical changes reported in RLS patients and shows an RLS-like behavioral phenotype. Previous studies with the BID-rodent model of RLS demonstrated increased sensitivity of cortical pyramidal cells to release glutamate from their striatal nerve terminals driving striatal circuits, a correlative finding of the cortical motor hyperexcitability of RLS patients. It was also found that BID in rodents leads to changes in the adenosinergic system, a downregulation of the inhibitory adenosine A

Indexed as

Corpus StriatumReceptor, Adenosine A1Receptor, Adenosine A2ARestless Legs SyndromeAnimalsBrainCerebral CortexDisease Models, AnimalGlutamic AcidIron DeficienciesMaleRatsVesicular Glutamate Transport Protein 1Vesicular Glutamate Transport Protein 2Glutamic AcidReceptor, Adenosine A1Receptor, Adenosine A2ASlc17a6 protein, ratSlc17a7 protein, ratVesicular Glutamate Transport Protein 1Vesicular Glutamate Transport Protein 2adenosine A1 receptoradenosine A2A receptorbrain iron deficiencycortico-striatal terminalsrestless legs syndromestriatumthalamo-striatal terminals

Identifiers

PMID35268590
PMCPMC8911604
OpenAlexW4213433801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.